Megaloblastic anemia—etiology and management
✍ Scribed by A. K. Saraya; M. K. Gupta
- Book ID
- 112880132
- Publisher
- Springer-Verlag
- Year
- 1987
- Tongue
- English
- Weight
- 698 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0019-5456
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Induction Chemotherapy and Post-Remission Imatinib Therapy for de Novo BCR-ABL-Positive AML To the Editor: Translocation t(9;22)(q34;q11) is found in 1-2% of newly diagnosed patients with de novo AML. The prognosis of Ph þ AML is very poor with a median survival time of only 7 months. We presen
Anemia is common after liver transplantation, with the incidence ranging from 4.3% to 28.2% depending on the criteria used to define anemia. The cause of anemia is unidentified in the majority of patients, and it is likely to be multifactorial. Immunosuppressive-medication-induced bone marrow suppre